The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this “Connectivity Map” resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, post-perturbation transcriptomics data are particularly suited for training computational models because the causal relationship between known perturbations (cause) and the measured post-perturbation gene expression (effect) allows for the modelling of mechanistic processes [11].”
From Benchmarking foundation cell models for post-perturbation RNA-seq prediction (2025) · cites this paper as [11]
In the citing paper
“Both Alakwaa’ and Luo’s pipelines use the CLUE platform, a cloud-based platform developed by the LINCS Center for signature-gene based drug ranking61.”
From ASGARD is a single-cell guided pipeline to aid repurposing of drugs (2023) · cites this paper as [61]
In the citing paper
“For example, in a classic paradigm inflammatory bowel disease (IBD) signatures were derived from surgical specimens and intersected with Connectivity Map70 data representing transcriptional readouts across a number of cell lines in response to treatment with many hundreds of drugs using a novel pattern-matching algorithm71. From this research the anticonvulsant drug topiramate was identified and”
From Exploiting machine learning for end-to-end drug discovery and development (2019) · cites this paper as [71]
In the citing paper
“Useful tools will include maps of evolutionary conservation (108) and chromatin state (140), as well as databases of cell-state signatures, such as genome-wide expression patterns, that may integrate aspects of cell biology under resting and provoked conditions (141).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [141]
In the citing paper
“It has been shown that compounds eliciting similar transcriptional signatures tend to share mechanisms of action.170,207−209”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [207]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Self-citationMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533
Research works printed but not linked: 7
- K. B. Glaser et al., Mol. Cancer Ther.2, 151 (2003).
- A. E. Wakeling, M. Dukes, J. Bowler, Cancer Res.51, 3867 (1991).
- J. Y. Vanderhoek, M. B. Feinstein, Mol. Pharmacol.16, 171 (1979).
- H. Hieronymus et al. Cancer Cell in press.
- Q. Yao et al., Clin. Cancer Res.9, 4483 (2003).
- T. Kubota et al., Cancer Res.58, 3344 (1998).
- G. Wei et al. Cancer Cell in press.
Cited by
Items 401–500 of 1,037
Tian, S., Zhang, J., Yuan, S., Wang, Q., Lv, C., Wang, J., Fang, J., Fu, L., Yang, J., Zu, X., et al. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad027 · Cited by 148
Molecular Concepts Analysis Links Tumors, Pathways, Mechanisms, and Drugs
Rhodes, D. R., Kalyana-Sundaram, S., Tomlins, S. A., Mahavisno, V., Kasper, N., Varambally, R., Barrette, T. R., Ghosh, D., Varambally, S., & Chinnaiyan, A. M. (2007) · Neoplasia · doi:10.1593/neo.07292 · Cited by 142
Lagunin, A. A., Goel, R. K., Gawande, D. Y., Pahwa, P., Gloriozova, T. A., Dmitriev, A. V., Ivanov, S. M., Rudik, A. V., Konova, V., Pogodin, P. V., et al. (2014) · Natural Product Reports · doi:10.1039/c4np00068d · Cited by 147
Using a Stem Cell–Based Signature to Guide Therapeutic Selection in Cancer
Shats, I., Gatza, M. L., Chang, J. T., Mori, S., Wang, J., Rich, J. N., & Nevins, J. R. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1735 · Cited by 147
Lagunin, A. A., Ivanov, S. M., Rudik, A. V., Filimonov, D. A., & Poroikov, V. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt322 · Cited by 147
Bioinformatics in translational drug discovery
Wooller, S. K., Benstead-Hume, G., Chen, X., Ali, Y., & Pearl, F. M. G. (2017) · Bioscience Reports · doi:10.1042/bsr20160180 · Cited by 147
Concrete Autoencoders for Differentiable Feature Selection and ReconstructionPreprint
Abid, A., Balin, M. F., & Zou, J. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1901.09346 · Cited by 147
Mitsos, A., Melas, I. N., Siminelakis, P., Chairakaki, A. D., Sáez-Rodríguez, J., & Alexopoulos, L. G. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000591 · Cited by 145
An Algorithmic Framework for Predicting Side Effects of Drugs
Atias, N., & Sharan, R. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0255 · Cited by 128
Yuan, B., Shen, C., Luna, A., Korkut, A., Marks, D. S., Ingraham, J., & Sander, C. (2021) · Cell Systems · doi:10.1016/j.cels.2020.11.013 · Cited by 125
Precision oncology in the age of integrative genomics
Kumar‐Sinha, C., & Chinnaiyan, A. M. (2018) · Nature Biotechnology · doi:10.1038/nbt.4017 · Cited by 145
Luczak, E. D., & Leinwand, L. A. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163156 · Cited by 143
Molecular targets of epigenetic regulation and effectors of environmental influences☆☆☆
Choudhuri, S., Cui, Y., & Klaassen, C. D. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2010.03.022 · Cited by 121
Systems Pharmacology to Predict Drug Toxicity: Integration Across Levels of Biological Organization
Bai, J. P. F., & Abernethy, D. R. (2012) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140248 · Cited by 146
Integration of phytochemicals and phytotherapy into cancer precision medicine
Efferth, T., Saeed, M. E. M., Mirghani, E., Alim, A., Yassin, Z., Saeed, E. M., Khalid, H. E., & Daak, S. (2017) · Oncotarget · doi:10.18632/oncotarget.17466 · Cited by 143
Advances and Challenges in Computational Target Prediction
Sydow, D., Burggraaff, L., Szengel, A., van Vlijmen, H. W. T., IJzerman, A. P., van Westen, G. J. P., & Volkamer, A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00832 · Cited by 126
Using artificial intelligence methods to speed up drug discovery
Álvarez-Machancoses, Ó., & Fernández-Martínez, J. L. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1621284 · Cited by 124
do Valle, Í. F., Roweth, H. G., Malloy, M. W., Moco, S., Barron, D., Battinelli, E. M., Loscalzo, J., & Barabási, A.-Ĺ. (2021) · Nature Food · doi:10.1038/s43016-021-00243-7 · Cited by 143
Recent advances and method development for drug target identification
Chan, J. N. Y., Nislow, C., & Emili, A. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.11.002 · Cited by 143
Behavioral screening for neuroactive drugs in zebrafish
Rihel, J., & Schier, A. F. (2011) · Developmental Neurobiology · doi:10.1002/dneu.20910 · Cited by 143
Chong, S. Z., Evrard, M., Devi, S., Chen, J., Lim, J. Y., See, P., Zhang, Y., Adrover, J. M., Lee, B., Tan, L., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20160800 · Cited by 142
Cheng, Y., Gunasegaran, B., Singh, H. D., Dutertre, C.-A., Loh, C. Y., Lim, J. Q., Crawford, J. C., Lee, H. K., Zhang, X., Lee, B., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.06.013 · Cited by 142
Wen, Z., Wang, Z. K., Wang, S., Ravula, R., Yang, L., Xu, J., Wang, C., Zuo, Z., Chow, M. S. S., Shi, L. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018278 · Cited by 142
Systematic evaluation of connectivity map for disease indications
Cheng, J., Yang, L., Kumar, V., & Agarwal, P. (2014) · Genome Medicine · doi:10.1186/s13073-014-0095-1 · Cited by 129
Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors
Ross‐Macdonald, P., de Silva, H., Guo, Q., Xiao, H., Hung, C.-Y., Penhallow, B. A., Markwalder, J. A., He, L., Attar, R. M., Lin, T.-A., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0826 · Cited by 142
Chemical Genetics–Based Target Identification in Drug Discovery
Cong, F., Cheung, A. K., & Huang, S.-M. A. (2011) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134639 · Cited by 145
Li, X., Xu, Y., Cui, H. S., Huang, T., Wang, D., Lian, B., Li, W., Qin, G., Chen, L., & Xie, L. (2017) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2017.05.008 · Cited by 141
Cisek, K., Krochmal, M., Klein, J., & Mischak, H. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv364 · Cited by 127
Construction of Drug Network Based on Side Effects and Its Application for Drug Repositioning
Ye, H., Liu, Q., & Jia, W. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087864 · Cited by 139
Dyle, M. C., Ebert, S. M., Cook, D. P., Kunkel, S. D., Fox, D. K., Bongers, K. S., Bullard, S. A., Dierdorff, J. M., & Adams, C. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556241 · Cited by 138
“In addition, Connectivity Map analysis indicates that tomatidine’s effects on mRNA expression in human cell lines approximate a mirror image of the changes in skeletal muscle mRNA expression that occur during skeletal muscle atrophy in humans.”
MethodNavigating the complexities of drug development for inflammatory bowel disease
Honap, S., Jairath, V., Danese, S., & Peyrin‐Biroulet, L. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-00953-0 · Cited by 138
Machine learning for perturbational single-cell omics
Ji, Y., Lotfollahi, M., Wolf, F. A., & Theis, F. J. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.016 · Cited by 137
Rana, S., Singla, A. K., Bajaj, A., Elci, S. G., Miranda, O. R., Mout, R., Yan, B., Jirik, F. R., & Rotello, V. M. (2012) · ACS Nano · doi:10.1021/nn302917e · Cited by 137
Mining data and metadata from the gene expression omnibus
Wang, Z., Lachmann, A., & Ma’ayan, A. (2018) · Biophysical Reviews · doi:10.1007/s12551-018-0490-8 · Cited by 138
Kim, J., & Orkin, S. H. (2011) · Genome Medicine · doi:10.1186/gm291 · Cited by 123
Genome-environment interactions that modulate aging: powerful targets for drug discovery
de Magalhães, J. P., Wuttke, D., Wood, S. H., Plank, M., & Vora, C. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004499 · Cited by 136
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia
Swarup, V., Hinz, F. I., Rexach, J. E., Noguchi, K.-I., Toyoshiba, H., Oda, A., Hirai, K., Sarkar, A., Seyfried, N. T., Cheng, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0223-3 · Cited by 136
Self-citationSato, M., Tsuda, K., Wang, L., Coller, J., Watanabe, Y., Glazebrook, J., & Katagiri, F. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001011 · Cited by 139
Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace
Singh, N., Chaput, L., & Villoutreix, B. O. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa034 · Cited by 137
Xia, H., Li, S., Li, X., Wang, W., Bian, Y., Wei, S., Grove, S., Wang, W., Vatan, L., Liu, J. R., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.141115 · Cited by 137
Drug target prioritization by perturbed gene expression and network information
Isik, Z., Baldow, C., Cannistraci, C. V., & Schroeder, M. (2015) · Scientific Reports · doi:10.1038/srep17417 · Cited by 135
Chemical informatics and target identification in a zebrafish phenotypic screen
Laggner, C., Kokel, D., Setola, V., Tolia, A., Lin, H., Irwin, J. J., Keiser, M. J., Cheung, C. Y. J., Minor, D. L., Roth, B. L., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.732 · Cited by 121
Computational polypharmacology: a new paradigm for drug discovery
Chaudhari, R. R., Tan, Z., Huang, B., & Zhang, S. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1280024 · Cited by 135
Non-kinase targets of protein kinase inhibitors
Munoz, L. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.266 · Cited by 135
Integrative Radiogenomic Profiling of Squamous Cell Lung Cancer
Abazeed, M. E., Adams, D. J., Hurov, K. E., Tamayo, P., Creighton, C. J., Sonkin, D., Giacomelli, A. O., Du, C., Fries, D. F., Wong, K.-K., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1616 · Cited by 124
Wu, L., Liu, Q., Ruan, X., Luan, X., Zhong, Y., Liu, J., Yan, J., & Li, X. (2023) · Biomedicines · doi:10.3390/biomedicines11071861 · Cited by 134
Molecular profiles of progesterone receptor loss in human breast tumors
Creighton, C. J., Osborne, C. K., van de Vijver, M. J., Foekens, J. A., Klijn, J. G. M., Horlings, H. M., Nuyten, D. S. A., Wang, Y., Zhang, Y., Chamness, G. C., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0017-2 · Cited by 134
Tardito, S., Isella, C., Médico, E., Marchiò, L., Bevilacqua, E., Hatzoglou, M., Bussolati, O., & Franchi‐Gazzola, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.026583 · Cited by 134
Modulatory profiling identifies mechanisms of small molecule-induced cell death
Wolpaw, A. J., Shimada, K., Skouta, R., Welsch, M. E., Akavia, U. D., Pe'er, D., Shaik, F., Bulinski, J. C., & Stockwell, B. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106149108 · Cited by 133
“More detailed descriptions of the experimental protocols are available on the website and in the publication about the project (37).”
BackgroundMethodRepositioning of the anthelmintic drug mebendazole for the treatment for colon cancer
Nygren, P., Fryknäs, M., Ågerup, B., & Larsson, R. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1539-5 · Cited by 133
Jiang, P., Green, S. J., Chlipala, G. E., Turek, F. W., & Vitaterna, M. H. (2019) · Microbiome · doi:10.1186/s40168-019-0724-4 · Cited by 134
Mottini, C., Napolitano, F., Li, Z., Gao, X., & Cardone, L. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.023 · Cited by 118
Ligands for the Nuclear Peroxisome Proliferator-Activated Receptor Gamma
Sauer, S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.06.010 · Cited by 134
THIERS, B. H. (2007) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70659-2 · Cited by 133
Auray, G., Keller, I., Python, S., Gerber, M., Bruggmann, R., Ruggli, N., & Summerfield, A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600672 · Cited by 130
Transcription Factor Inhibition: Lessons Learned and Emerging Targets
Chen, A. W., & Koehler, A. N. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.004 · Cited by 133
Network-Based Drug-Target Interaction Prediction with Probabilistic Soft Logic
Fakhraei, S., Huang, B., Raschid, L., & Getoor, L. C. (2014) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2014.2325031 · Cited by 131
Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies
Galindez, G., Matschinske, J., Rose, T. D., Sadegh, S., Salgado-Albarrán, M., Späth, J., Baumbach, J., & Pauling, J. K. (2021) · Nature Computational Science · doi:10.1038/s43588-020-00007-6 · Cited by 130
Qi, X., Zhao, L., Tian, C., Li, Y., Chen, Z.-L., Huo, P., Chen, R., Liu, X., Wan, B., Yang, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53457-1 · Cited by 130
A simple and robust method for connecting small-molecule drugs using gene-expression signatures
Zhang, S.-D., & Gant, T. W. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-258 · Cited by 114
Komurov, K., Tseng, J., Muller, M., Seviour, E. G., Moss, T. J., Yang, L., Nagrath, D., & Ram, P. T. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.25 · Cited by 116
Proteasome deubiquitinases as novel targets for cancer therapy
D’Arcy, P., & Linder, S. T. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.07.011 · Cited by 130
Gene set analysis methods: a systematic comparison
Mathur, R., Rotroff, D., Ma, J., Shojaie, A., & Motsinger-Reif, A. (2018) · BioData Mining · doi:10.1186/s13040-018-0166-8 · Cited by 91
Mesnage, R., Phedonos, A., Arno, M. J., Balu, S., Corton, J. C., & Antoniou, M. N. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx101 · Cited by 129
Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer
Claerhout, S., Lim, J. Y., Choi, W., Park, Y.-Y., Kim, K., Kim, S.-B., Lee, J.-S., Mills, G. B., & Cho, J. Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024662 · Cited by 117
Campbell, J. D., McDonough, J. E., Zeskind, J. E., Hackett, T. L., Pechkovsky, D. V., Brandsma, C.-A., Suzuki, M., Gosselink, J. V., Liu, G., Alekseyev, Y. O., et al. (2012) · Genome Medicine · doi:10.1186/gm367 · Cited by 128
SigCom LINCS: data and metadata search engine for a million gene expression signatures
Evangelista, J. E., Clarke, D. J. B., Xie, Z., Lachmann, A., Jeon, M., Chen, K., Jagodnik, K. M., Jenkins, S. L., Kuleshov, M. V., Wojciechowicz, M. L., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac328 · Cited by 128
Systems approaches and algorithms for discovery of combinatorial therapies
Feala, J. D., Cortes, J., Duxbury, P. M., Piermarocchi, C., McCulloch, A. D., & Paternostro, G. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.51 · Cited by 96
Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy
Stankov, M. V., El Khatib, M., Kumar Thakur, B., Heitmann, K., Panayotova-Dimitrova, D., Schoening, J., Bourquin, J. P., Schweitzer, N., Leverkus, M., Welte, K., et al. (2014) · Leukemia · doi:10.1038/leu.2013.264 · Cited by 121
Haure-Mirande, J.-V., Audrain, M., Fanutza, T., Kim, S. H., Klein, W. L., Glabe, C., Readhead, B., Dudley, J. T., Blitzer, R. D., Wang, M., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1737-3 · Cited by 127
“Drug-induced gene expression fold change was obtained from the Connectivity Map database [42], which consists of 6100 individual experiments, representing 1309 unique compounds.”
MethodInfluentialExtending the small-molecule similarity principle to all levels of biology with the Chemical Checker
Duran-Frigola, M., Pauls, E., Guitart-Pla, O., Bertoni, M., Alcalde, V., Amat, D., Juan-Blanco, T., & Aloy, P. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0502-7 · Cited by 126
Cerchietti, L. C., Hatzi, K., Caldas-Lopes, E., Yang, S. N., Figueroa, M. E., Morin, R. D., Hirst, M., Mendez, L., Shaknovich, R., Cole, P. A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42869 · Cited by 119
Predictive approaches for drug combination discovery in cancer
Madani Tonekaboni, S. A., Soltan Ghoraie, L., Manem, V. S. K., & Haibe-Kains, B. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbw104 · Cited by 115
Drug Repositioning in Glioblastoma: A Pathway Perspective
Tan, S. K., Jermakowicz, A., Mookhtiar, A. K., Nemeroff, C. B., Schürer, S. C., & Ayad, N. G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00218 · Cited by 116
Applications of Artificial Intelligence in Drug Repurposing
Wan, Z., Sun, X., Li, Y., Chu, T., Hao, X., Cao, Y., & Zhang, P. (2025) · Advanced Science · doi:10.1002/advs.202411325 · Cited by 127
Learning for Personalized Medicine: A Comprehensive Review From a Deep Learning Perspective
Zhang, S., Bamakan, S. M. H., Qu, Q., & Li, S. (2019) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2018.2864254 · Cited by 125
“The authors in [75] developed”
BackgroundMethodInfluentialMa, T., Tan, C., Zhang, H., Wang, M., Ding, W., & Li, S. (2010) · Molecular BioSystems · doi:10.1039/b914024g · Cited by 125
A novel computational approach for drug repurposing using systems biology
Peyvandipour, A., Saberian, N., Shafi, A., Donato, M., & Drăghici, S. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty133 · Cited by 126
The genesis and evolution of bead-based multiplexing
Graham, H., Chandler, D. J., & Dunbar, S. A. (2019) · Methods · doi:10.1016/j.ymeth.2019.01.007 · Cited by 125
Slonim, D. K., Koide, K., Johnson, K. L., Tantravahi, U., Cowan, J. M., Jarrah, Z., & Bianchi, D. W. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903909106 · Cited by 117
Weston, D. J., Gunter, L. E., Rogers, A., & Wullschleger, S. D. (2008) · BMC Systems Biology · doi:10.1186/1752-0509-2-16 · Cited by 111
Diurnal variation of the human adipose transcriptome and the link to metabolic disease
Loboda, A., Kraft, W. K., Fine, B., Joseph, J., Nebozhyn, M., Zhang, C., He, Y., Yang, X., Wright, C., Morris, M., et al. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-7 · Cited by 124
“The Connectivity Map (also known as CMAP) is a collection of genome-wide transcriptional data from cultured human cells treated with different kinds of compounds.”
InfluentialSelf-citationComputational investigations of hERG channel blockers: New insights and current predictive models
Villoutreix, B. O., & Taboureau, O. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.003 · Cited by 124
Iskar, M., Zeller, G., Zhao, X., van Noort, V., & Bork, P. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.11.010 · Cited by 124
The Power of Sophisticated Phenotypic Screening and Modern Mechanism-of-Action Methods
Wagner, B. K., & Schreiber, S. L. (2016) · Cell Chemical Biology · doi:10.1016/j.chembiol.2015.11.008 · Cited by 111
Wang, C., Chiao, C.-C., Phan, N. N., Li, C.-Y., Sun, Z., Jiang, J., Hung, J., Chen, Y., Yen, M., Weng, T.-Y., et al. (2020) · PubMed Central · Cited by 124
Application of omics- and multi-omics-based techniques for natural product target discovery
Zhang, H., Lv, C., Zhang, L., Guo, X., Shen, Y., Nagle, D. G., Zhou, Y., Liu, S., Zhang, W., & Luan, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111833 · Cited by 124
Ahangari, F., Becker, C., Foster, D. G., Chioccioli, M., Nelson, M., Beke, K. M., Wang, X., Justet, A., Adams, T. S., Readhead, B. P., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202010-3832oc · Cited by 124
Xu, R., & Wang, Q. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-181 · Cited by 107
Iskar, M., Zeller, G., Blattmann, P., Campillos, M., Kuhn, M., Kaminska, K. H., Runz, H., Gavin, A., Pepperkok, R., van Noort, V., et al. (2013) · Molecular Systems Biology · doi:10.1038/msb.2013.20 · Cited by 118
Xu, L., Chen, Y., Mayakonda, A., Koh, L., Chong, Y. K., Buckley, D. L., Sandanaraj, E., Lim, S. W., Lin, R. Y.-T., Ke, X.-Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712363115 · Cited by 111
Rahman, M. R., Islam, T., Turanli, B., Zaman, T., Faruquee, H. M., Rahman, M. M., Mollah, M. N. H., Nanda, R. K., Arga, K. Y., Gov, E., et al. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.12.011 · Cited by 117
Highly multiplexed single-cell RNA-seq by DNA oligonucleotide tagging of cellular proteins
Gehring, J., Hwee Park, J., Chen, S., Thomson, M., & Pachter, L. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0372-z · Cited by 122
Computational drug repurposing: approaches, evaluation of in silico resources and case studies
Tanoli, Z., Fernández‐Torras, A., Özcan, U. O., Kushnir, A., Nader, K. M., Gadiya, Y., Fiorenza, L., Ianevski, A., Vähä-Koskela, M. J. V., Miihkinen, M., et al. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01164-x · Cited by 123
A Gene Signature-Based Approach Identifies mTOR as a Regulator of p73
Rosenbluth, J. M., Mays, D. J., Pino, M. F., Tang, L. J., & Pietenpol, J. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00305-08 · Cited by 112
Bond, P. (2016) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-016-0118-y · Cited by 121
“By querying the Connectivity Map [79] with the data they gathered, they identified ursolic acid as a potential pharmacologic compound which might inhibit skeletal muscle atrophy.”
MethodNatural Product Inspired N‐Terminal Hsp90 Inhibitors: From Bench to Bedside?
Khandelwal, A., Crowley, V. M., & Blagg, B. S. J. (2015) · Medicinal Research Reviews · doi:10.1002/med.21351 · Cited by 121
A modular approach for integrative analysis of large-scale gene-expression and drug-response data
Kutalik, Z., Beckmann, J. S., & Bergmann, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1397 · Cited by 122
Gene expression–based discovery of atovaquone as a STAT3 inhibitor and anticancer agent
Xiang, M., Kim, H., Ho, V. T., Walker, S. R., Bar-Natan, M., Anahtar, M., Liu, S., Toniolo, P. A., Kroll, Y., Jones, N., et al. (2016) · Blood · doi:10.1182/blood-2015-07-660506 · Cited by 109
A cloud-based workflow to quantify transcript-expression levels in public cancer compendia
Tatlow, P., & Piccolo, S. R. (2016) · Scientific Reports · doi:10.1038/srep39259 · Cited by 101
Metadata
- Authors
- Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G., Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Crawford, Emily D.
- Golub, Todd R.
- ORCID
- Venue
- Science
- Published
- 2006-09-29
- Volume
- 313
- Issue
- 5795
- Pages
- 1929-1935
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2121604817
- Cited by
- 5,257
- References
- 41
- Citations by year
- 2026: 226 · 2025: 285 · 2024: 332 · 2023: 370 · 2022: 416 · 2021: 406 · 2020: 383 · 2019: 385 · 2018: 280 · 2017: 288 · 2016: 296 · 2015: 259 · 2014: 217 · 2013: 241 · 2012: 219
- FWCI
- 118.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene expression signatures, small molecules, drug action, gene perturbation, mechanism of action, cultured human cells, functional genomics
- MeSH terms
- Alzheimer Disease, Cell Line, Dexamethasone, Drug Evaluation, Preclinical, Enzyme Inhibitors, Estrogens, Humans, Obesity, Phenothiazines, Software, Gene Expression, Databases, Factual, HSP90 Heat-Shock Proteins, Drug Resistance, Neoplasm, Sirolimus, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Limonins, Cell Line, Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.